Potential interventions such as blocking SARS-CoV-2/ACE2 binding, immune regulation and continuous renal replacement therapies (CRRT) for protecting kidney function in COVID-19 patients, particularly for AKI cases, are optional methods that may prevent fatalities. The gene discussed is ACE2; the disease is acute kidney injury.